503

Compound name
Ivosidenib
Alt Name
AG-120
Tibsovo
Compound Image
Ivosidenib.png
SMILES
C1CC(=O)N([C@@H]1C(=O)N(C2=CC(=CN=C2)F)[C@@H](C3=CC=CC=C3Cl)C(=O)NC4CC(C4)(F)F)C5=NC=CC(=C5)C#N
MW
583.00
Brutto
C28H22ClF3N6O3
InChI
InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1
InChI Key
WIJZXSAJMHAVGX-DHLKQENFSA-N
Approval Jurisdiction
2018 FDA, 2023 EMA
Approved for clinical use
Acute Myeloid Leukemia (AML) And Cholangiocarcinoma
CAS
1448347-49-6
PubChem CID
71657455
Approved Drug List
1